Evaluation of the Application of PEGylated Recombinant Human Granulocyte Stimulating Factor Injection (PEG-rhG-CSF) in Chemotherapy of Elderly Lymphoma Patients

NCT03870412 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

485

Enrollment

INDUSTRY

Sponsor class

Conditions

Elderly Lymphoma Patients

Interventions

DRUG: PEG-rhG-CSF

Sponsor

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.